101 related articles for article (PubMed ID: 2015552)
1. The expression of proliferative-associated nuclear antigen p105 in gastric carcinoma.
Yonemura Y; Ohoyama S; Kimura H; Kamata T; Matsumoto H; Yamaguchi A; Kosaka T; Miwa K; Miyazaki I
Cancer; 1991 May; 67(10):2523-8. PubMed ID: 2015552
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of p105 expression and malignancy in gastric cancers].
Yonemura Y; Oyama S; Kimura H; Kamata T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):118-21. PubMed ID: 1674814
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in advanced gastric cancers.
Kimura H; Yonemura Y; Epstein AL
Cancer; 1991 Nov; 68(10):2175-80. PubMed ID: 1913456
[TBL] [Abstract][Full Text] [Related]
5. Proliferation-associated nuclear antigen p105 as a marker for metastasis of human gastric cancer.
Ohyama S; Yonemura Y; Kimura H; Kosaka T; Miyazaki I; Sasaki T
J Cancer Res Clin Oncol; 1991; 117(6):583-6. PubMed ID: 1683872
[TBL] [Abstract][Full Text] [Related]
6. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms.
Fitzgibbons PL; Turner RR; Appley AJ; Bishop PC; Nichols PW; Epstein AL; Apuzzo ML; Chandrasoma PT
Am J Clin Pathol; 1988 May; 89(5):640-4. PubMed ID: 2895977
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of mitotic cells using anti-p105 monoclonal antibody to analyze the mode of action of etoposide and podophyllotoxin in human gastric cancer cells.
Ohyama S; Yonemura Y; Tsugawa K; Miyazaki I; Tanaka M; Sasaki T
Jpn J Cancer Res; 1991 Nov; 82(11):1258-62. PubMed ID: 1684358
[TBL] [Abstract][Full Text] [Related]
10. Proliferative activity in gastric cancer determined with cell cycle-related monoclonal antibodies Ki-67 and p105: analysis by flow cytometry.
Kimura H; Yonemura Y; Miyazaki I
J Surg Oncol; 1992 Nov; 51(3):174-8. PubMed ID: 1359195
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of pituitary tumors. Correlation of nuclear antigen p105 and DNA content with clinical behavior.
Fitzgibbons PL; Appley AJ; Turner RR; Bishop PC; Parker JW; Breeze RE; Weiss MH; Apuzzo ML
Cancer; 1988 Oct; 62(8):1556-60. PubMed ID: 3048631
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
Takamura H; Yonemura Y; Hirono Y; Ninomiya I; Sahara H; Tsugawa K; Matsumoto H; Sugiyama K; Fujimura T; Nishimura G
Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Yokogi H
Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
[TBL] [Abstract][Full Text] [Related]
14. Changes in cell nuclei during S phase: progressive chromatin condensation and altered expression of the proliferation-associated nuclear proteins Ki-67, cyclin (PCNA), p105, and p34.
Bruno S; Crissman HA; Bauer KD; Darzynkiewicz Z
Exp Cell Res; 1991 Sep; 196(1):99-106. PubMed ID: 1831764
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative estimation of malignancy of gastric cancer by DNA ploidy and proliferative activities].
Yonemura Y; Miyazaki I
Rinsho Byori; 1990 Sep; 38(9):1053-8. PubMed ID: 2232266
[TBL] [Abstract][Full Text] [Related]
16. NO38 expression and nucleolar counts are correlated with cellular DNA content but not with proliferation parameters in colorectal carcinomas.
De Angelis PM; Stokke T; Clausen OP
Mol Pathol; 1997 Aug; 50(4):201-8. PubMed ID: 9350304
[TBL] [Abstract][Full Text] [Related]
17. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle.
Landberg G; Tan EM; Roos G
Exp Cell Res; 1990 Mar; 187(1):111-8. PubMed ID: 1967582
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous nuclear antigen and DNA content quantitation using paraffin-embedded colonic tissue and multiparameter flow cytometry.
Bauer KD; Clevenger CV; Endow RK; Murad T; Epstein AL; Scarpelli DG
Cancer Res; 1986 May; 46(5):2428-34. PubMed ID: 3516382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
